Replacement Heart Valves
Edwards Lifesciences posts Q3 sales, profit gains, affirms outlook
Edwards Lifesciences (NYSE:EW) said its sales and profits grew at a double-digit clip during the 3rd quarter and affirmed its forecast for the rest of 2013.
TAVI: Germany’s TCT goes head-to-head against Medtronic, St. Jude | MassDevice.com On Call
MASSDEVICE ON CALL — Germany-based medical device company Transcatheter Technologies GmbH is making a bold stride into the transcatheter aortic valve implantation space, announcing 1st-in-man implantation of a device it says it intends to be the "the world’s best repositionable heart valve."
Medtronic launches trial of retrievable heart valve
Supreme Court declines to hear Medtronic appeal of Edwards Lifesciences win
Device makers team up for next-gen TAVI system
Medical device makers Symetis Inc. and Endoluminal Sciences are reaching across oceans to co-develop a new generation of transcatheter aortic valve implantation systems featuring "active anti-paravalvular leak technology."
The duo entered into a license agreement to incorporate Endoluminal Sciences’ anti-leak system into Symetis’ Acurate TA and Acurate TF product lines, according to a press release.
Edwards Lifesciences lands expanded approval for Sapien heart valve
Edwards Lifesciences faces shareholder class action over Sapien TAVI system
PLC Systems raises $1.8M through common stock
Medical device maker PLC Systems (PINK:PLCSF) touted a new $1.75 million raise, which the company plans to use to fund its ongoing U.S. pivotal trial for the RenalGuard system.